Business Context and Reporting Period
This Form 8-K is a current report filed by Spherix Incorporated (not Dominari Holdings Inc.) on December 5, 2012, covering events occurring on November 30, 2012, and December 3, 2012. The filing details the disposition of a subsidiary and significant changes to the Board of Directors and executive management.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. Specific financial figures disclosed relate to transactional and severance costs:
- Asset Disposition Proceeds: Less than $1,000.00 (nominal consideration for the sale of Spherix Consulting, Inc.).
- Severance to Dr. Claire L. Kruger: $310,801.00.
- Severance to Robert L. Clayton: $212,180.00.
Debt, liquidity, and margin data are not provided in this filing text.
Material Changes
The following material changes occurred during the reporting period:
- Asset Disposition: On December 3, 2012, the Company sold all capital stock of its consulting subsidiary, Spherix Consulting, Inc., to ChromaDex, Inc.
- Board Resignations: On November 30, 2012, four directors resigned: Dr. Claire L. Kruger, Dr. Robert A. Lodder, Aris Melissaratos, and Thomas B. Peter.
- Executive Departures: Dr. Claire L. Kruger resigned as CEO/COO (effective December 3, 2013).
- Executive Appointments: Dr. Robert A. Lodder was appointed Principal Executive Officer (effective December 3, 2012), and Robert L. Clayton was appointed Secretary.
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, management commentary on future strategy, or a discussion of risks and contingencies beyond the immediate events reported. The primary focus is on the structural changes to the company's governance and asset base.
Investor Verification Checklist
- Verify the strategic rationale for selling the Spherix Consulting subsidiary for nominal consideration.
- Confirm the composition of the new Board of Directors following the resignation of four members.
- Review the employment agreements for Dr. Lodder and Mr. Clayton to understand the terms of their new roles and the severance obligations.
- Assess the impact of the CEO/COO departure (effective 2013) on operational continuity.